Keeping Pace in Lung Cancer - HER2: Unveiling New Horizons in NSCLC Treatment - a podcast by ReachMD

CME credits: 0.25

Valid until: 15-11-2024

Claim your CME credit at https://reachmd.com/programs/cme/keeping-pace-in-lung-cancer-her2-unveiling-new-horizons-in-nsclc-treatment/16083/

We now have an FDA-approved targeted therapy to treat HER2-mutated NSCLC. Drs. Aggarwal and Sands discuss the most current clinical data, including management of adverse events.

=

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD